|
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
|
5R44CA123994-05
|
$1,000,000
|
Lebowitz, Michael
|
20/20 GENESYSTEMS, INC.
|
|
Serum GP88 biomarker as a surrogate marker for disease progression in breast canc
|
1R43CA153800-01A1
|
$113,320
|
Serrero, Ginette
|
A AND G PHARMACEUTICAL, INC.
|
|
Novel Targeted Therapy for Breast Cancer
|
5R44CA124179-03
|
$578,078
|
Serrero, Ginette
|
A AND G PHARMACEUTICAL, INC.
|
|
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
|
5R44CA112852-04
|
$1,096,389
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Automated Systems for Detection and Molecular Characterization of Circulating Tum
|
5R44CA122444-05
|
$1,006,336
|
LUO, YULING
|
ADVANCED CELL DIAGNOSTICS, INC.
|
|
Phase I SBIR TOPIC 307 Imaging Agents for Assessment of Breast Tumor Margins
|
N43CO110118-000
|
$249,912
|
WALSER, BRYAN
|
AKROTOME IMAGING
|
|
Novel Diffusion Tensor Imaging CAD for Breast Cancer
|
N43CO110075-000
|
$192,886
|
PENN, ALAN
|
ALAN PENN&ASSOCIATES INC
|
|
The 3D whole Body Distribution of NIR transferrin using FRET tomography imaging
|
1R21CA161782-01
|
$178,809
|
BARROSO, MARGARIDA
|
ALBANY MEDICAL COLLEGE
|
|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-18
|
$272,648
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Old Drugs and New Strategies for Tumor Metastasis
|
5R01CA129598-04
|
$241,530
|
BRESNICK, ANNE
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Tumor microenvironments determing migration, dissemination and dormancy
|
1U54CA163131-01
|
$838,472
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
MOTILITY AND INVASION
|
3P01CA100324-09S1
|
$72,007
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
MOTILITY AND INVASION
|
5P01CA100324-09
|
$2,023,001
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Signal Transduction & Actin During Amoeboid Chemotaxis
|
5R01CA150344-23
|
$353,827
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S1
|
$249,624
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S2
|
$249,624
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S3
|
$74,922
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-39
|
$3,725,702
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EMT, Extravasation and metastasis by N-Cadherin signaling
|
3R01CA135061-03S1
|
$68,792
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EMT, Extravasation and metastasis by N-Cadherin signaling
|
5R01CA135061-03
|
$334,117
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
R-Cadherin in Breast Cancer Suppression
|
5R01CA136854-03
|
$334,117
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Macrophages and Tumor Angiogenesis
|
5R01CA131270-04
|
$318,015
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Identifying the Mechanisms Governing Mena-Induced Tumor Cell Dissemination
|
1F32CA159663-01
|
$48,398
|
Roh, Minna
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
microRNA expression profiling of benign breast tissue and breast cancer risk
|
5R01CA142942-02
|
$813,924
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS
|
5R01CA077522-10
|
$283,878
|
SEGALL, JEFFREY
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-37
|
$99,689
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Influence of Fasting Status and Specimen Processing Time on Adipokine Levels
|
1R03CA143956-01A1
|
$73,491
|
Strickler, Howard
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
|
1R01CA164468-01
|
$799,600
|
Verkhusha, Vladislav
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Bifunctional T cell receptor based immunotherapeutics
|
5R44CA097550-07
|
$979,275
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
5U01CA098710-08
|
$288,303
|
GAPSTUR, SUSAN
|
AMERICAN CANCER SOCIETY, INC.
|
|
Community Clinical Oncology Program
|
5U10CA037422-24
|
$4,282,002
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-13
|
$7,455,878
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Targeted tumoricidal bacteria
|
5R44CA126023-03
|
$386,199
|
ZHAO, MING
|
ANTICANCER, INC.
|
|
Biomarker Detection Using NAPPA Tumor Antigen Arrays
|
5U01CA117374-07
|
$639,172
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
5R01CA125063-05
|
$375,520
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-22
|
$406,165
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
REGULATION OF GENETIC STABILITY BY THE INT6 FAMILY
|
5R01CA090464-09
|
$264,170
|
CHANG, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
|
Progesterone Receptor Binding to Specific DNA Sequences
|
5R01CA046938-23
|
$242,682
|
EDWARDS, DEAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
5R01CA137019-02
|
$289,164
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
3R01CA072038-14S1
|
$49,857
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
5R01CA072038-14
|
$291,193
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Breast Cancer Research Training Program
|
5T32CA090221-09
|
$114,203
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of the Adenovirus E4-ORF1 Oncoprotein
|
5R01CA058541-17
|
$307,553
|
Javier, Ronald
|
BAYLOR COLLEGE OF MEDICINE
|
|
Molecularly guided multimodal theranostics for breast cancer
|
5R01CA151962-02
|
$338,318
|
JOSHI, AMIT
|
BAYLOR COLLEGE OF MEDICINE
|
|
Prevalence of CD24 epigenetic silencing in breast tumors and ERalpha status
|
1R03CA150027-01A1
|
$78,250
|
Kaipparettu, Benny
|
BAYLOR COLLEGE OF MEDICINE
|
|
C/EBPb Modulates Macrophages and Tumor-Initiating Cells During Preneoplastic Prog
|
1K99CA154605-01A1
|
$158,552
|
LaMarca, Heather
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of Mammary Stem Cells
|
3R01CA127857-04S1
|
$48,293
|
LEWIS, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of Mammary Stem Cells
|
5R01CA127857-04
|
$308,958
|
LEWIS, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Characterization and targeting BRIT1 deficiency in breast cancer
|
1R01CA155151-01
|
$324,738
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Oncogene susceptibility: physiological state & breast cell differentiation
|
5R01CA124820-02
|
$308,957
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|